Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Cetyl Myristoleate (CMO) | Palmitoylethanolamide (PEA) | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | — | — |
| Timing | — | — |
| Cycle Duration | — | — |
| Evidence Level | Limited-Moderate | Strong |
Fatty acid ester with anti-inflammatory and joint-lubricating properties. Modulates immune response by inhibiting 5-lipoxygenase and modulating prostaglandin synthesis. Reduces joint inflammation and improves range of motion in arthritic conditions.
Endocannabinoid-like lipid that activates PPAR-alpha and indirectly enhances endocannabinoid tone. Potent anti-inflammatory and analgesic without acting directly on CB1/CB2. Reduces mast cell activation, neuroinflammation, and chronic pain.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →